EQUITA assisted ACS Dobfar
ACS Dobfar, an Italian chemical-pharmaceutical group leader worldwide in the manufacturing of Active Pharmaceuticals Ingredients (APIs) and Final Dosage Forms (FDFs) in the antibiotic sector worldwide, received a Eur 175 million term loan financing through an underwriting deal closed with Unicredit and Natixis in Italy.
ACS Dobfar achieved a consolidated turnover of EUR 586 million in 2015.
K Finance (Clairfield Italy) assisted ACS Dobfar in the preparation and structuring of the deal and throughout the entire underwriting process. The legal advisor was Baker & McKenzie.